The Effect of Human Recombinant Erythropoietin on Prevention of Anemia of Prematurity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Iranian Journal of Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and/or recombinant human erythropoietin.

  2006cited by this paper
• The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants.

  2005cited by this paper
• Case–Control Study

  2005cited by this paper
• Is there a place for epoetin alfa in managing anemia during critical illness?

  2004cited by this paper
• Recombinant Human Erythropoietin Use in Intensive Care

  2002cited by this paper
• Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.

  2002cited by this paper
• Human Recombinant Erythropoietin in the Prevention and Treatment of Anemia of Prematurity

  2002cited by this paper
• Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.

  2001cited by this paper
• Prophylaxis of anemia of prematurity with erythropoietin. Case control study

  2000cited by this paper
• Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.

  2000cited by this paper
• Recombinant human erythropoietin in anemia of prematurity.

  1999cited by this paper
• Hematopoietic growth factor levels in term and preterm infants.

  1999cited by this paper
• Serum concentration of granulocyte colony stimulating factor in term and preterm infants

  1997cited by this paper
• Serum erythropoietin concentrations fail to increase after significant phlebotomy losses in ill preterm infants.

  1997cited by this paper
• Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea.

  1997cited by this paper
• The role of erythropoietin in the anemia of prematurity.

  1997cited by this paper
• Early treatment of premature infants with recombinant human erythropoietin

  1993cited by this paper
• Therapeutic implications of dysregulated colony-stimulating factor expression in neonates [editorial; comment]

  1993cited by this paper
• In Which Neonates Does Early Recombinant Human Erythropoietin Treatment Prevent Anemia of Prematurity? Results of a Randomized, Controlled Study

  1993cited by this paper
• Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity

  1992cited by this paper
• Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.

  1992cited by this paper
• Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

  1991cited by this paper
• Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.

  1991cited by this paper
• Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity

  1991cited by this paper
• Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

  1990cited by this paper
• Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity".

  1988cited by this paper
• Circulating erythroid progenitors in the anemia of prematurity.

  1987cited by this paper
• Anemia of prematurity.

  1981cited by this paper

• Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

  2019cites this paper
• Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

  2019cites this paper
• Effect of Oral Erythropoietin in Prevention of Anemia of Prematurity

  2018influential citation
• Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

  2014cites this paper
• Factores de riesgo implicados en la necesidad de transfusión sanguínea en recién nacidos de muy bajo peso tratados con eritropoyetina

  2010cites this paper
• Enterally Recombinant Erythropoietin Stimulates Erythropoiesis in Preterm Infants

  2007cites this paper